TNSN99017A1 - Gene de streptomyces avermitilis commandant le rapport des avermectines b2 : b1 et procede nouveau pour la production d'avermectines. - Google Patents

Gene de streptomyces avermitilis commandant le rapport des avermectines b2 : b1 et procede nouveau pour la production d'avermectines.

Info

Publication number
TNSN99017A1
TNSN99017A1 TNTNSN99017A TNSN99017A TNSN99017A1 TN SN99017 A1 TNSN99017 A1 TN SN99017A1 TN TNSN99017 A TNTNSN99017 A TN TNSN99017A TN SN99017 A TNSN99017 A TN SN99017A TN SN99017 A1 TNSN99017 A1 TN SN99017A1
Authority
TN
Tunisia
Prior art keywords
avermectins
gene
avermitilized
streptomyces
report
Prior art date
Application number
TNTNSN99017A
Other languages
English (en)
Inventor
Jonelle Stutzman-Engwall Kim
Katoh Yoshihiro
Alastair Irvine Mcarthur Hamish
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN99017A1 publication Critical patent/TNSN99017A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'INVENTION CONCERNE DES MOLECULES POLYNUCLEOTIDIQUES COMPRENANT DES SEQUENCES CODANT POUR UN PRODUIT DU GENE AveC, POUR MODIFIER LE RAPPORT DES CATEGORIES 2:1 DES AVERMECTINES DANS DES CULTURES DE S.AVERMITILIS PAR FERMENTATION. ELLE CONCERNE EGALEMENT DES VECTEURS, DES CELLULES HOTES ET DES SOUCHES MUTANTES DE S.AVERMITILIS DANS LESQUELS LE GENE AveC A ETE INACTIVE OU MUTE. APPLICATION : UTILISATION DE CES AVERMECTINES ET DE COMPOSITIONS LES CONTENANT COMME COMPOSES PARASITICIDES.
TNTNSN99017A 1998-02-13 1999-02-10 Gene de streptomyces avermitilis commandant le rapport des avermectines b2 : b1 et procede nouveau pour la production d'avermectines. TNSN99017A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7463698P 1998-02-13 1998-02-13

Publications (1)

Publication Number Publication Date
TNSN99017A1 true TNSN99017A1 (fr) 2005-11-10

Family

ID=22120706

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN99017A TNSN99017A1 (fr) 1998-02-13 1999-02-10 Gene de streptomyces avermitilis commandant le rapport des avermectines b2 : b1 et procede nouveau pour la production d'avermectines.

Country Status (32)

Country Link
EP (1) EP1053335A1 (fr)
JP (2) JP2002503473A (fr)
KR (3) KR20040099389A (fr)
CN (2) CN1521180A (fr)
AP (1) AP9901463A0 (fr)
AR (1) AR018085A1 (fr)
AU (1) AU752343C (fr)
BG (1) BG64911B1 (fr)
BR (1) BR9907893A (fr)
CA (2) CA2521289A1 (fr)
CO (1) CO5070698A1 (fr)
DZ (1) DZ2720A1 (fr)
EA (1) EA003905B1 (fr)
GT (1) GT199900014A (fr)
HN (1) HN1999000008A (fr)
HR (1) HRP20000539A2 (fr)
HU (1) HUP0100784A3 (fr)
IL (2) IL137610A0 (fr)
IS (1) IS5567A (fr)
MA (1) MA24760A1 (fr)
NO (1) NO20004044L (fr)
NZ (2) NZ505676A (fr)
OA (1) OA11449A (fr)
PA (1) PA8467601A1 (fr)
PE (1) PE20000352A1 (fr)
PL (1) PL194270B1 (fr)
SK (1) SK11722000A3 (fr)
TN (1) TNSN99017A1 (fr)
TW (1) TW585910B (fr)
WO (1) WO1999041389A1 (fr)
YU (1) YU50900A (fr)
ZA (1) ZA991138B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9907893A (pt) * 1998-02-13 2000-11-14 Pfizer Prod Inc Gene de streptomyces avermitilis que dirige a proporção de avermectinas b2:b1
US6248579B1 (en) * 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
JP3884651B2 (ja) * 1999-08-12 2007-02-21 ファイザー・プロダクツ・インク Ｂ２アベルメクチン：ｂ１アベルメクチンの比を指示するストレプトミセス・アベルミティリス遺伝子
US7630836B2 (en) * 2001-05-30 2009-12-08 The Kitasato Institute Polynucleotides
RU2293117C2 (ru) * 2002-02-12 2007-02-10 Пфайзер Продактс Инк. Ген streptomyces avermitilis и его применение для изменения соотношения авермектинов b2:b1
CN107338210B (zh) * 2017-09-05 2021-08-17 天津科技大学 一种阿维链霉菌合成培养基及其发酵液的制备方法
CN111269296B (zh) * 2020-03-06 2021-11-05 山东大学 一种nLsA蛋白及其结构基因和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4429042A (en) * 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
IN167980B (fr) * 1987-01-23 1991-01-19 Pfizer
ES2054822T3 (es) * 1987-10-23 1994-08-16 Pfizer Procedimiento para la produccion de agliconas de avermectinas y sus cultivos.
JPH0747171B2 (ja) * 1988-09-20 1995-05-24 株式会社東芝 圧延機の設定方法および装置
DE69023036T2 (de) * 1989-03-31 1996-06-13 Merck & Co Inc Klonierung von Streptomyces avermitilis Genen zur Biosynthese von Avermectin und Verfahren zu ihrer Verwendung.
US5252474A (en) * 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
JP2888586B2 (ja) * 1990-03-05 1999-05-10 社団法人北里研究所 エバーメクチンの特定成分を選択生産するための微生物およびその選択的製造法
FI942725A (fi) * 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
BR9907893A (pt) * 1998-02-13 2000-11-14 Pfizer Prod Inc Gene de streptomyces avermitilis que dirige a proporção de avermectinas b2:b1

Also Published As

Publication number Publication date
SK11722000A3 (sk) 2001-04-09
IL137610A0 (en) 2001-07-24
KR20040053390A (ko) 2004-06-23
GT199900014A (es) 2000-07-25
IS5567A (is) 2000-07-20
BG64911B1 (bg) 2006-08-31
NZ505676A (en) 2003-02-28
EA003905B1 (ru) 2003-10-30
WO1999041389A1 (fr) 1999-08-19
YU50900A (sh) 2004-03-12
HN1999000008A (es) 1999-10-29
DZ2720A1 (fr) 2003-09-01
HUP0100784A2 (hu) 2001-06-28
BR9907893A (pt) 2000-11-14
ZA991138B (en) 2000-08-14
TW585910B (en) 2004-05-01
IL183596A0 (fr) 2007-09-20
PL194270B1 (pl) 2007-05-31
CA2521289A1 (fr) 1999-08-19
OA11449A (en) 2003-12-03
AU1887899A (en) 1999-08-30
HUP0100784A3 (en) 2004-10-28
JP2004283174A (ja) 2004-10-14
EA200000758A1 (ru) 2001-04-23
PA8467601A1 (es) 2000-09-29
NO20004044L (no) 2000-10-11
HRP20000539A2 (en) 2001-04-30
KR20010052166A (ko) 2001-06-25
CO5070698A1 (es) 2001-08-28
PL342468A1 (en) 2001-06-04
KR20040099389A (ko) 2004-11-26
CA2320031A1 (fr) 1999-08-19
CN1297485A (zh) 2001-05-30
AU752343C (en) 2005-11-03
EP1053335A1 (fr) 2000-11-22
JP4011036B2 (ja) 2007-11-21
MA24760A1 (fr) 1999-10-01
JP2002503473A (ja) 2002-02-05
NZ518657A (en) 2003-10-31
NO20004044D0 (no) 2000-08-11
AR018085A1 (es) 2001-10-31
AP9901463A0 (en) 1999-03-31
KR100499214B1 (ko) 2005-07-07
CN1521180A (zh) 2004-08-18
PE20000352A1 (es) 2000-05-16
BG104759A (en) 2001-04-30
AU752343B2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
DE60026142T2 (de) Verfahren zur herstellung von oligosaccharide
EA200602068A1 (ru) Ферментативное получение тонких химических соединений
FR2540516A1 (fr) Procede de production de proteines correspondant a la toxine diphterique
Jordan Effect of vancomycin on the synthesis of the cell wall mucopeptide of Staphylococcus aureus
TNSN99017A1 (fr) Gene de streptomyces avermitilis commandant le rapport des avermectines b2 : b1 et procede nouveau pour la production d'avermectines.
EP0915981B1 (fr) Procede pour isoler des genes de biosynthese pour pseudo-oligosaccharides issus de streptomyces glaucescens gla.o et leur utilisation
EP0990704A3 (fr) Enzyme formant des saccharide non réducteurs, enzyme libérant le trehalose et procédé de fabrication de saccharides utilisant ces enzymes
TNSN00170A1 (fr) Gene de streptomyces avermitilis dirigeant le rapport des avermectines b2 : b1
TNSN00171A1 (fr) Gene de streptomyces avermitilis commandant le rapport des avermectines b2 : b1
DE60127948T2 (de) Verfahren zur herstellung von avermectinderivaten
KR20190112484A (ko) β-아가라아제 DagA 효소의 과발현 유도 기술의 개발
DE10109166A1 (de) Avilamycin-Derivate
KR100321304B1 (ko) 테이코플라닌의 정제방법
JPWO2008047674A1 (ja) ニストースを選択的に分解するβ−フラクトフラノシダーゼおよびそれを用いた１−ケストース高含量溶液の製造方法
KR100197357B1 (ko) 미생물 셀룰로오스 생산용 배지 및 그를 이용한 미생물 셀룰로오스의 제조방법
FR2627507B1 (fr) Procede de diminution de la viscosite des milieux en cas d'excretion de polymeres viscosifiants annexes dans les procedes de fermentation
Jizba et al. Insecticidal activity of pyrrolizine derivatives isolated from Streptomyces griseus
US4535083A (en) Cleavage products of 4',6'-didesoxy-4'-thio-,6'-amino-hepturonic acid nucleosides
RS70004A (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectin
Nonaka et al. Fermentative production of milbemycin α11 and α14: Appearance of morphological mutants during large-scale fermentation
SU1557165A1 (ru) Способ получени биологически активных веществ
RU2034924C1 (ru) Штамм streptomyces ornatus - продуцент кератиназы
CN105002235B (zh) 一种利用酶制备葡磷酰胺及其类似物的方法
KR830000618B1 (ko) 신 항생물질 sf-2050b물질의 제조법
KR900003304B1 (ko) 항생물질 니코마이신 x,z의 제조방법